Showing results (1321-1330 of 2,560) with videos related to
Sort By:
Pageof 256
Reviews of Infectious Diseases|January 1, 1989
Damaging effect of toxic shock syndrome toxin 1 on chick embryo cells in vitroA Drumm, J C de Azavedo, J P ArbuthnottReviews of Infectious Diseases|January 1, 1989
Active surveillance for toxic shock syndrome in the United States, 1986S Gaventa, A L Reingold, A W Hightower, et al.Reviews of Infectious Diseases|January 1, 1989
Reaction of toxic shock syndrome toxin 1 with endothelium of human umbilical cord veinV M Kushnaryov, H S MacDonald, R F Reiser, et al.Reviews of Infectious Diseases|July 1, 1986
Liability for infectious diseases in day care: legal and practical considerationsC S Stevenson, G S Sterne, K O StephensReviews of Infectious Diseases|July 1, 1988
Recent developments in beta-lactamase research and their implications for the futureK BushReviews of Infectious Diseases|July 1, 1988
Bacterial active-site serine penicillin-interactive proteins and domains: mechanism, structure, and evolutionJ M GhuysenReviews of Infectious Diseases|July 1, 1988
Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteriaT Sawai, A Yamaguchi, R HirumaReviews of Infectious Diseases|July 1, 1988
Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporinsW E Sanders, C C SandersReviews of Infectious Diseases|July 1, 1988
Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genesW Sougakoff, S Goussard, G Gerbaud, et al.Reviews of Infectious Diseases|July 1, 1988
Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporinsR Labia, A Morand, K Tiwari, et al.Pageof 256